VRTX | Vertex Pharmaceuticals

254.86 -4.84 (-1.86%)

VRTX Price Profile

Open

$255.01

CLOSE

$254.86

DAY RANGE

252.87 - 258.00

52 WEEK RANGE

176.36 - 292.75

MARKET CAP

57.61B

Trading volume

409.13K

Prev. Close

259.70

50 Day MA

210.96

Shares Outstanding

254.25M

Public Float

253.68M

Average Volume

1.98M

Beta

0.63

PEG Ratio

1.14

Shares Shorted

2.91M

% OF SHARES SHORTED

1.15%

Short Ratio

1.37

1 Year Performance

-1.27%

Diluted EPS (TTM)

8.34

Q Revenue Growth

0.29

Ebitda

2.77B

Gross Profit (TTM)

3.64B

Total Cash (MRQ)

6.96B

Total Debt (MRQ)

876.8M

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Vertex Pharmaceuticals (VRTX) company profile

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is a biotechnology company. The company discovers, develops, manufactures, and commercializes small molecule drugs for patients with serious diseases. The firm solutions treat cystic fibrosis, infectious diseases, and autoimmune diseases.

Latest VRTX News

AD